Catalent to Invest $350 Million in Its Indiana Facility

Catalent reports that it will make a multi-year $350 million investment at its facility in Bloomington, IN, to expand biologics drug substance and drug product manufacturing capabilities.
Company officials say the expansion includes the installation of new 2,000-liter single-use…

Source: www.genengnews.com – Read more